ALLO
Allogene Therapeutics, Inc.Closed1.29−0.11 −7.86%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.30 +0.78%
Open
1.39
Prev close
1.40
Day range
1.301.40
52-week range
1.044.46
Volume
6.42M1.14×
Mkt cap
445.68M
P/E ttm
—
Fwd P/E
-2.09
EPS ttm
-0.6600
Div yield
0.00%
Earnings
Aug 12, 2026
From 52w high
−71.08%
ALLO shareholders
ALLO Ownership
13F / N-PORT filings via Yahoo
Institutions
82.6%
92.9% of the float
Insiders
11.0%
officers and directors
Institutional holders
280
filing positions
Top 10 institutions
50.1%
8 adding · 0 trimming
Top Institutions
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| Blackrock Inc. | 8.73% | 30.15M | $38.89M | +57.9% | Jun 30, 2026 |
| Frazier Life Sciences Management, L.P. | 6.50% | 22.45M | $28.96M | +491.2% | Jun 30, 2026 |
| Pfizer Inc | 6.38% | 22.03M | $28.42M | 0.0% | Jun 30, 2026 |
| State Street Corporation | 5.51% | 19.03M | $24.54M | +119.7% | Jun 30, 2026 |
| TPG GP A, LLC | 5.42% | 18.72M | $24.14M | 0.0% | Jun 30, 2026 |
| Sio Capital Management, LLC | 3.86% | 13.32M | $17.19M | +100.0% | Jun 30, 2026 |
| Primecap Management Company | 3.80% | 13.12M | $16.93M | +56.6% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 3.52% | 12.17M | $15.69M | +75.8% | Jun 30, 2026 |
| FMR, LLC | 3.48% | 12.01M | $15.49M | +655.4% | Jun 30, 2026 |
| Citadel Advisors Llc | 2.92% | 10.09M | $13.01M | +48.5% | Jun 30, 2026 |
Top Funds
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.71% | 12.82M | $16.54M | +7.5% | Aug 31, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.91% | 10.04M | $12.96M | −2.9% | Aug 31, 2026 |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 2.72% | 9.39M | $12.11M | +75.0% | Jun 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.51% | 8.67M | $11.18M | +77.6% | Jun 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.97% | 6.81M | $8.79M | +0.7% | Aug 31, 2026 |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 1.01% | 3.48M | $4.48M | 0.0% | Jul 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 1.00% | 3.44M | $4.44M | −10.1% | Jun 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.93% | 3.22M | $4.16M | +71.3% | Jun 30, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.84% | 2.91M | $3.75M | +0.8% | Jul 31, 2026 |
| abrdn Life Sciences Investors | 0.79% | 2.73M | $3.52M | +86.8% | Jun 30, 2026 |
Institutions report quarterly, up to 45 days after the quarter ends, so these positions can be months old. Change compares the share count with the holder's previous filing. Insider transactions are on the overview page (INSD).